ciprofloxacin and piperacillin, tazobactam drug combination

ciprofloxacin has been researched along with piperacillin, tazobactam drug combination in 53 studies

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.89)	18.2507
2000's	12 (22.64)	29.6817
2010's	34 (64.15)	24.3611
2020's	6 (11.32)	2.80

Authors

Authors	Studies
Falagas, ME; McDermott, L; Snydman, DR	1
Buchman, TG; Cheadle, WG; Cohn, SM; Haverstock, DC; Jungerwirth, S; Kowalsky, SF; Lipsett, PA; Milsom, JW; O'Marro, S; Rochefort, EV; Yellin, AE	1
Evans, ME	1
Burroughs, A; Fisher, N; Hastings, M; Kibbler, C; Mutimer, D; O'Grady, J; Patch, D; Philpott-Howard, J; Rolando, N; Wade, J; Wendon, J	1
Evangelista, AT; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yee, YC	1
Kuti, JL; Nicolau, DP; Sun, HK	1
Bassoul, B; Causse, L; Dareau, S; Delire, V; Eledjam, JJ; Gros, T; Javitary, W	1
Mannaerts, L; Van der Wurff, AA; Wolfhagen, FH	1
Bardenstein, R; Carmeli, Y; Chmelnitsky, I; Goland, S; Hammer Muntz, O; Navon Venezia, S; Zimhony, O	1
Adelman, MH; Cohn, SM; Gilliland-Johnson, KK; Paladino, JA	1
Aldeyab, MA; Bailie, R; Elshibly, SM; Hanley, J; Hughes, CM; Kearney, MP; McDowell, DA; McElnay, JC; McMahon, MA; Scott, MG	1
Cho, YB; Choi, CH; Jang, CH; Park, H; Park, IY	1
Aldeyab, MA; Hanley, J; Kearney, MP; McElnay, JC; Scott, MG	1
Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY	1
Best, L; Boonlayangoor, S; Hebert, C; Lin, M; Pitrak, D; Tolentino, J; Villaran, R; Weber, SG	1
Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF	1
Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH	1
Amer, MZ; Bandey, M; Bukhari, A; Nemenqani, D	1
Bak, N; Holds, JM; Papanicolas, LE	1
Holodniy, M; Lucero, CA; Mercier, RC; Nguyen, N; Oda, G; Ryono, RA; Schirmer, PL	1
Aziz, MN; Desa, MN; Idris, SN; Taib, NM	1
Bonten, MJ; Bootsma, MC; Campbell, J; Chau, NV; Farrar, J; Hoa, NT; Hoang, NV; Loan, HT; Nga, TT; Schultsz, C; Thao, le TP; Thuy, TT; Vien, le M; Wit, F; Yen, LM	1
Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H	1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C	1
Fortier, LC; Garneau, JR; Valiquette, L	1
Chu, X; Guo, YY; Liu, QZ; Shen, LM; Wang, J; Zhang, CL	1
Andersen, MH; Arendrup, MC; Bestle, MH; Cozzi-Lepri, A; Drenck, NE; Grarup, J; Hein, L; Helweg-Larsen, J; Jensen, JU; Johansen, ME; Larsen, KM; Lauritsen, AØ; Lundgren, B; Lundgren, JD; Løken, J; Mohr, T; Møller, JK; Olesen, B; Petersen, JA; Reinholdt, K; Strange, D; Søe-Jensen, P; Thormar, K; Tousi, H; Østergaard, C	1
Han, XY; Li, L; Tarrand, JJ	1
Bhattacharya, S; Bhaumik, J; Chandy, M; Goel, G; Mukherjee, S	1
Bartoletti, R; Bjerklund Johansen, TE; Brugnolli, A; Cai, T; Eccher, C; Lanzafame, P; Luciani, LG; Malossini, G; Mirone, V; Pickard, R; Tiscione, D; Verze, P; Wagenlehner, FM	1
Amornchai, P; Day, NPJ; Langla, S; Limmathurotsakul, D; Peacock, SJ; White, NJ; Wuthiekanun, V	1
Alauzet, C; Benayad, H; Bertaux, A; Claudon, M; Lemarié, C; Malikov, S; Mandry, D; Risse, J; Settembre, N; Wahl, D; Zuily, S	1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F	1
Ambeba, EJ; Cooper, JN; Deans, KJ; Lodwick, DL; Mahida, JB; Minneci, PC; Moss, RL; Nacion, KM; Sulkowski, JP	1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ	1
Cho, H; Eun Kim, D; Hee Park, S; Ho Jang, C; Huang, X; Jeong Yoon, E; Lan Piao, Y; Lee, K; Yeon Lee, S; Zhan, CG	1
Carvalheira, A; Casquete, R; Silva, J; Teixeira, P	1
Lipsky, BA; Mutluoglu, M	1
Anupurba, S; Banerjee, T	1
Ashraf, T; Darwish, D; Ghazawi, A; Mohsin, J; Pál, T; Petersen, JE; Sonnevend, A	1
Goodlet, KJ; Nailor, MD; Nicolau, DP	1
Heather, CS; Maley, M	1
Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR	1
Amick, T; Bush, K; Gregson, A; Hemarajata, P; Holzmeyer, C; Humphries, RM; Yang, S	1
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A	1
Escrig Sos, J; Gil Fortuño, M; Granel Villach, L; Igual Adell, R; Martínez Ramos, D; Moreno Muñoz, R; Sabater Vidal, S; Soria Martín, R	1
Antonelli, A; Cantón, R; Coppi, M; de Vogel, C; Gijón, D; Giske, CG; Hasan, B; Maruri, A; Rossolini, GM; Tellapragada, C; van Wamel, W; Verbon, A	1
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K	1
Daneman, N; Elligsen, M; Katz, K; Lam, PW; Lo, J; MacFadden, D; Teitelbaum, D; Vermeiren, C	1
Ardebili, A; Bagheri, H; Goharrizi, MASB; Hjimohammadi, A; Izanloo, A; Jamali, A; Shahri, FN	1
Arezzo, A; Bonomo, LD; Ferguglia, A; Mingrone, G; Morino, M; Nicotera, A; Olandese, F; Pentassuglia, G; Veglia, S	1
Gales, AC; Sahm, DF; Stone, G; Utt, E; Wise, MG	1

Trials

5 trial(s) available for ciprofloxacin and piperacillin, tazobactam drug combination

Article	Year
Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Annals of surgery, 2000, Volume: 232, Issue:2 Topics: Abdomen; Abdominal Abscess; Administration, Oral; Anti-Infective Agents; Appendicitis; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies	2000
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:6 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae; Female; Fever; Humans; Liver Transplantation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prospective Studies; Staphylococcus aureus	2003
Pharmacoeconomics of ciprofloxacin plus metronidazole vs. piperacillin-tazobactam for complicated intra-abdominal infections. Surgical infections, 2008, Volume: 9, Issue:3 Topics: Abdominal Abscess; Adult; Aged; Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	2008
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity. PloS one, 2013, Volume: 8, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins	2013
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime. Critical care medicine, 2015, Volume: 43, Issue:3 Topics: Age Factors; Aged; Anti-Bacterial Agents; APACHE; Candidiasis, Invasive; Cefuroxime; Ciprofloxacin; Critical Illness; Denmark; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Single-Blind Method; Thienamycins	2015

Other Studies

48 other study(ies) available for ciprofloxacin and piperacillin, tazobactam drug combination

Article	Year
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins	1997
Selection of oxacillin resistance in oxacillin-sensitive Staphylococcus aureus through exposure to ciprofloxacin but not piperacillin/tazobactam. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:8 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Microbial Sensitivity Tests; Oxacillin; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Selection, Genetic; Staphylococcus aureus	2002
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40 Suppl 2 Topics: beta-Lactams; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; United States	2005
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program. Critical care medicine, 2005, Volume: 33, Issue:10 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins	2005
[Postoperative pneumonia: nosocomial, predictable, iatrogenic, preventable or not?]. Annales francaises d'anesthesie et de reanimation, 2006, Volume: 25, Issue:4 Topics: Alcoholism; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Carcinoma, Squamous Cell; Ciprofloxacin; Cross Infection; Disease Susceptibility; Fatal Outcome; Humans; Iatrogenic Disease; Immunocompromised Host; Liver Cirrhosis, Alcoholic; Male; Malnutrition; Malpractice; Middle Aged; Mouth; Neck Dissection; Neoplasm Recurrence, Local; Oxygen; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Tongue Neoplasms	2006
[Interstitial nephritis attributed to treatment with piperacillin-tazobactam and with ciprofloxacin]. Nederlands tijdschrift voor geneeskunde, 2006, Apr-08, Volume: 150, Issue:14 Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Nephritis, Interstitial; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2006
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9 Topics: beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Thienamycins	2006
Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit. International journal of antimicrobial agents, 2008, Volume: 32, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Ciprofloxacin; Cross Infection; Data Interpretation, Statistical; Drug Combinations; Electrophoresis, Gel, Pulsed-Field; Hand Disinfection; Hygiene; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Personnel, Hospital; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcal Infections; Tazobactam	2008
The use of piperacillin-tazobactam coated tympanostomy tubes against ciprofloxacin-resistant Pseudomonas biofilm formation: an in vitro study. International journal of pediatric otorhinolaryngology, 2009, Volume: 73, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Adhesion; Bacteriological Techniques; Biofilms; Ciprofloxacin; Coated Materials, Biocompatible; Drug Resistance, Bacterial; Equipment Contamination; Equipment Design; Humans; Materials Testing; Microscopy, Electron, Scanning; Middle Ear Ventilation; Otitis Media, Suppurative; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Silicones; Surface Properties	2009
Health-related quality of life after intensive care unit discharge: A comparison between 2 standard antibiotic regimens. Infection control and hospital epidemiology, 2009, Volume: 30, Issue:8 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Health Status; Humans; Intensive Care Units; Outcome Assessment, Health Care; Patient Discharge; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality of Life; Surveys and Questionnaires	2009
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence	2010
Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains. Scandinavian journal of infectious diseases, 2010, Volume: 42, Issue:6-7 Topics: Adult; Antifungal Agents; Candida; Candidiasis; Ciprofloxacin; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Logistic Models; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors	2010
Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Ciprofloxacin; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Young Adult	2010
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained. American journal of surgery, 2011, Volume: 201, Issue:3 Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin	2011
Neonatal meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia. Journal of infection in developing countries, 2011, Oct-13, Volume: 5, Issue:10 Topics: Anti-Bacterial Agents; Ciprofloxacin; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Saudi Arabia; Treatment Outcome	2011
Meningitis and pneumonitis caused by pet rodents. The Medical journal of Australia, 2012, Feb-20, Volume: 196, Issue:3 Topics: Adult; Animals; Anti-Bacterial Agents; C-Reactive Protein; Ceftriaxone; Ciprofloxacin; Female; Fusobacterium Infections; Humans; Hypoxia; Meningitis, Bacterial; Penicillanic Acid; Pets; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Rats; Respiratory Distress Syndrome; Streptobacillus; Thrombocytopenia	2012
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs. Infection control and hospital epidemiology, 2012, Volume: 33, Issue:4 Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; Hospitals, Veterans; Humans; Imipenem; Meropenem; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins; United States; Vancomycin	2012
Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital. The Southeast Asian journal of tropical medicine and public health, 2012, Volume: 43, Issue:1 Topics: ADP Ribose Transferases; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cefepime; Ceftazidime; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Hospitals; Humans; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Pseudomonas aeruginosa	2012
Effects of infection control measures on acquisition of five antimicrobial drug-resistant microorganisms in a tetanus intensive care unit in Vietnam. Intensive care medicine, 2013, Volume: 39, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftazidime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Humans; Infant; Infant, Newborn; Infection Control; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tetanus; Vietnam; Young Adult	2013
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1 Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index	2014
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam. BMC infectious diseases, 2014, Jan-15, Volume: 14 Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin	2014
Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China. BMC infectious diseases, 2014, May-15, Volume: 14 Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; China; Ciprofloxacin; Dysentery, Bacillary; Female; Galanin; Genes, Bacterial; Genotype; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Shigella; Substance P; Virulence	2014
Microbiological and clinical features of four cases of catheter-related infection by Methylobacterium radiotolerans. Journal of clinical microbiology, 2015, Volume: 53, Issue:4 Topics: Aged, 80 and over; Anti-Bacterial Agents; Catheter-Related Infections; Child; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Methylobacterium; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult	2015
Epidemiology of antimicrobial resistance in an oncology center in eastern India. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:7 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Cancer Care Facilities; Carbapenems; Ceftazidime; Ciprofloxacin; Clindamycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Feces; Fluconazole; Gentamicins; Humans; India; Methicillin-Resistant Staphylococcus aureus; Mycoses; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Yeasts	2015
Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship. European urology, 2016, Volume: 69, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Europe; Female; Gentamicins; Guideline Adherence; Humans; Klebsiella; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urologic Surgical Procedures; Urology	2016
Antimicrobial Disk Susceptibility Testing of Leptospira spp. Using Leptospira Vanaporn Wuthiekanun (LVW) Agar. The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:2 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Leptospira; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination	2015
Infected Abdominal Aortic Aneurysm Attributable to Haemophilus influenzae: Rapid Changes of Imaging Findings. Circulation, 2015, Aug-18, Volume: 132, Issue:7 Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortography; Blood Vessel Prosthesis Implantation; C-Reactive Protein; Ciprofloxacin; Diagnostic Imaging; Haemophilus Infections; Haemophilus influenzae; Humans; Leukocyte Count; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Tomography, X-Ray Computed	2015
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2016
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:1 Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection	2016
Effectiveness of Patient Choice in Nonoperative vs Surgical Management of Pediatric Uncomplicated Acute Appendicitis. JAMA surgery, 2016, 05-01, Volume: 151, Issue:5 Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Ciprofloxacin; Family; Female; Health Care Costs; Humans; Laparoscopy; Male; Metronidazole; Patient Participation; Patient Preference; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome	2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin	2016
Molecular modeling and redesign of alginate lyase from Pseudomonas aeruginosa for accelerating CRPA biofilm degradation. Proteins, 2016, Volume: 84, Issue:12 Topics: Acetylation; Alginates; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Biocatalysis; Biofilms; Ciprofloxacin; Cloning, Molecular; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Gene Expression; Glucuronic Acid; Hexuronic Acids; Hydrolysis; Kinetics; Molecular Dynamics Simulation; Mutation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polysaccharide-Lyases; Protein Domains; Protein Engineering; Protein Structure, Secondary; Pseudomonas aeruginosa; Recombinant Proteins; Sequence Alignment; Structural Homology, Protein	2016
Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat. International journal of food microbiology, 2017, Feb-21, Volume: 243 Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Chickens; Ciprofloxacin; Cross Infection; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Red Meat; Sulbactam; Swine; Trimethoprim, Sulfamethoxazole Drug Combination	2017
Non-surgical treatment of diabetic foot osteomyelitis. The lancet. Diabetes & endocrinology, 2017, Volume: 5, Issue:8 Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic Foot; Humans; Male; Osteomyelitis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	2017
Risk factors associated with fluoroquinolone-resistant enterococcal urinary tract infections in a tertiary care university hospital in north India. The Indian journal of medical research, 2016, Volume: 144, Issue:4 Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Fluoroquinolones; Hospitals, University; Humans; India; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pregnancy; Risk Factors; Tertiary Care Centers; Urinary Tract Infections	2016
Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman. Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:3 Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Oman; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Protein Isoforms; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination	2018
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin	2017
Automated direct screening for resistance of Gram-negative blood cultures using the BD Kiestra WorkCell. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins	2018
Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Retrospective Studies; Tertiary Care Centers; Thienamycins; Treatment Outcome	2018
Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy. The Journal of antimicrobial chemotherapy, 2018, 05-01, Volume: 73, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Gene Expression Profiling; Humans; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Real-Time Polymerase Chain Reaction; Selection, Genetic; Serratia Infections; Serratia marcescens; Whole Genome Sequencing	2018
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients. JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam	2018
[Biliary microbiote in cholecystectomized patients: Review of empirical antibiotherapy]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bile; Cholecystectomy; Cholecystitis; Ciprofloxacin; Escherichia coli; Female; Gram-Negative Bacteria; Humans; Klebsiella; Male; Metronidazole; Microbial Sensitivity Tests; Microbiota; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult	2019
Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:10 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Calorimetry; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Italy; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Netherlands; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Spain; Sweden	2020
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections. Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:3(Suppleme Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2021
Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 11-14, Volume: 75, Issue:10 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Ertapenem; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination	2022
Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran. International microbiology : the official journal of the Spanish Society for Microbiology, 2022, Volume: 25, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Colistin; Deoxyribonucleases; Drug Resistance, Bacterial; Genotype; Gentamicins; Humans; Imipenem; Iran; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Pancreatic Elastase; Phospholipases; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Virulence Factors	2022
Outcomes of surgical treatment of diverticular abscesses after failure of antibiotic therapy. Updates in surgery, 2023, Volume: 75, Issue:4 Topics: Abdominal Abscess; Abscess; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Colectomy; Diverticulitis, Colonic; Diverticulosis, Colonic; Drainage; Humans; Metronidazole; Piperacillin, Tazobactam Drug Combination; Retrospective Studies	2023
Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019. The Journal of antimicrobial chemotherapy, 2023, 07-05, Volume: 78, Issue:7 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Combinations; Escherichia coli; Incidence; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa	2023